354 related articles for article (PubMed ID: 18555812)
1. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
[TBL] [Abstract][Full Text] [Related]
2. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Nappi C; Di Spiezio Sardo A; Greco E; Tommaselli GA; Giordano E; Guida M
Obstet Gynecol; 2005 Jan; 105(1):53-60. PubMed ID: 15625142
[TBL] [Abstract][Full Text] [Related]
3. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Massaro M; Di Carlo C; Gargano V; Formisano C; Bifulco G; Nappi C
Contraception; 2010 Mar; 81(3):209-14. PubMed ID: 20159176
[TBL] [Abstract][Full Text] [Related]
4. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
Paoletti AM; Orrù M; Lello S; Floris S; Ranuzzi F; Etzi R; Zedda P; Guerriero S; Fratta S; Sorge R; Mallarini G; Melis GB
Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333
[TBL] [Abstract][Full Text] [Related]
5. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Nappi C; Di Spiezio Sardo A; Acunzo G; Bifulco G; Tommaselli GA; Guida M; Di Carlo C
Contraception; 2003 May; 67(5):355-9. PubMed ID: 12742557
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
Castelo-Branco C; Vicente JJ; Pons F; Martínez de Osaba MJ; Casals E; Vanrell JA
J Reprod Med; 2001 Oct; 46(10):875-9. PubMed ID: 11725730
[TBL] [Abstract][Full Text] [Related]
7. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
Di Carlo C; Gargano V; Sparice S; Tommaselli GA; Bifulco G; Schettino D; Nappi C
Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):388-93. PubMed ID: 23859010
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
[TBL] [Abstract][Full Text] [Related]
10. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
Oner G; Muderris II
Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
[TBL] [Abstract][Full Text] [Related]
12. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
Anttila L; Kunz M; Marr J
Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
[TBL] [Abstract][Full Text] [Related]
13. Effects of drospirenone/estrogen combinations on bone metabolism.
Christiansen C
Climacteric; 2005 Oct; 8 Suppl 3():35-41. PubMed ID: 16203654
[TBL] [Abstract][Full Text] [Related]
14. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
Vescovi JD; VanHeest JL; De Souza MJ
Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
[TBL] [Abstract][Full Text] [Related]
15. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density.
Endrikat J; Mih E; Düsterberg B; Land K; Gerlinger C; Schmidt W; Felsenberg D
Contraception; 2004 Mar; 69(3):179-87. PubMed ID: 14969664
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
[TBL] [Abstract][Full Text] [Related]
18. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
[TBL] [Abstract][Full Text] [Related]
19. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
Klipping C; Duijkers I; Trummer D; Marr J
Contraception; 2008 Jul; 78(1):16-25. PubMed ID: 18555813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
